KANABO GROUP PLC Logo

KANABO GROUP PLC

A digital health firm focused on cannabis products and telehealth services.

KNB | IL

Overview

Corporate Details

ISIN(s):
GB00BYQCS703
LEI:
213800XPJFSNWJIYKN52
Country:
United Kingdom
Address:
Churchill House, NW4 4DJ London

Description

Kanabo Group PLC is a digital health company focused on the research, development, and commercialization of cannabis-derived products. The company distributes cannabis-derived formulations for medical patients and non-THC products for CBD consumers. Its research and development efforts create proprietary, patent-pending formulas for conditions such as sleep and central nervous system (CNS) disorders. A key component of its offering is the VapePod®, a medically certified vaporization device that enables precise, metered-dosing of cannabis extracts. The company also operates The GP Service, a telehealth platform providing digital health services, including video consultations and online prescriptions, which integrates primary care with its specialist medicine offerings.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2025-12-11 12:45
Disposal of Subsidiary: The GP Service Limited
English 7.8 KB
2025-11-28 17:15
Appointment of Joint Administrators
English 10.8 KB
2025-03-04 08:00
Revenue Growth, Trading and Operational Update
English 19.6 KB
2025-01-06 08:00
Directorate Change
English 11.3 KB
2024-11-19 10:55
The GP Service Wins Award
English 9.2 KB
2024-10-31 10:48
Correction Director/PDMR Shareholding
English 27.2 KB
2024-10-29 12:39
Director/PDMR Shareholding
English 26.7 KB
2024-09-30 15:50
Half-year Report
English 307.5 KB
2024-08-28 15:31
Director/PDMR Shareholding
English 35.2 KB
2024-06-27 17:49
Result of AGM
English 23.0 KB
2024-06-04 08:00
Expansion:14 New Clinics Partnership with Treat-It
English 16.6 KB
2024-05-31 11:30
Notice of AGM
English 12.0 KB
2024-04-30 15:15
Annual Financial Report
English 895.4 KB
2024-03-28 08:00
Expansion of Treat It to Mental Health Treatments
English 14.0 KB
2024-03-27 18:11
Holding(s) in Company
English 24.2 KB

Automate Your Workflow. Get a real-time feed of all KANABO GROUP PLC filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for KANABO GROUP PLC

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for KANABO GROUP PLC via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.